Who owns ACHIEVE LIFE SCIENCES, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ACHV from SEC Form 13F filings across 132 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 132 institutions disclosed 95.2M shares of ACHIEVE LIFE SCIENCES, INC. worth $765.2M — about 90.3% of shares outstanding; the largest disclosed holder is Frazier Life Sciences Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
132
13F holders
$765.2M
value, 2026 filers
90.3%
of shares outstanding (95.2M sh)
35
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ACHV's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 7.6M | $61.6M | 1.5% | 7.2% | 0.0% |
| 2 | TPG GP A, LLC | 6.9M | $55.6M | 1.4% | 6.5% | 0.0% |
| 3 | venBio Partners LLC | 5.9M | $47.9M | 9.6% | 5.6% | 0.0% |
| 4 | Venrock Adviser, LLC | 5.5M | $44.5M | 2.2% | 5.2% | +100.0% |
| 5 | BlackRock, Inc. | 5.5M | $44.4M | 0.0% | 5.2% | +4.1% |
| 6 | Paradigm Biocapital Advisors LP | 5.0M | $40.1M | 0.8% | 4.7% | 0.0% |
| 7 | Propel Bio Management, LLC | 3.9M | $31.3M | 16.6% | 3.7% | -4.2% |
| 8 | JPMORGAN CHASE & CO | 3.8M | $29.1M | 0.0% | 3.6% | +11632.8% |
| 9 | MARSHALL WACE, LLP | 3.8M | $30.5M | 0.0% | 3.6% | 0.0% |
| 10 | STATE STREET CORP | 3.7M | $30.1M | 0.0% | 3.5% | +26.2% |
| 11 | EVENTIDE ASSET MANAGEMENT, LLC | 3.6M | $28.9M | 0.4% | 3.4% | +60.9% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 3.5M | $28.2M | 0.0% | 3.3% | -16.0% |
| 13 | Logos Global Management LP | 3.2M | $25.9M | 1.4% | 3% | -41.0% |
| 14 | FRANKLIN TEMPLETON INC | 3.1M | $21.9M | 0.0% | 3% | -36.8% |
| 15 | Janus Henderson Group Ltd.NEW | 2.8M | $22.3M | 0.0% | 2.6% | new |
| 16 | Vivo Capital, LLC | 2.8M | $22.3M | 2.4% | 2.6% | 0.0% |
| 17 | ORBIMED ADVISORS LLCNEW | 2.3M | $19.0M | 0.3% | 2.2% | new |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 2.2M | $17.5M | 0.0% | 2% | +4.6% |
| 19 | Boxer Capital Management, LLCNEW | 2.1M | $17.4M | 1.5% | 2% | new |
| 20 | WELLINGTON MANAGEMENT GROUP LLP | 1.6M | $13.3M | 0.0% | 1.6% | +15.6% |
| 21 | Alyeska Investment Group, L.P. | 975,722 | $7.9M | 0.0% | 0.9% | -49.3% |
| 22 | LPL Financial LLC | 973,585 | $7.9M | 0.0% | 0.9% | +7.9% |
| 23 | Simplify Asset Management Inc. | 932,105 | $7.5M | 0.1% | 0.9% | -34.9% |
| 24 | Bank of New York Mellon Corp | 753,900 | $6.1M | 0.0% | 0.7% | +245.6% |
| 25 | NORTHERN TRUST CORP | 743,368 | $6.0M | 0.0% | 0.7% | -0.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.